Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of radiotherapy market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market.
What is the Expert Analysis about the Future Growth of Radiotherapy Market?
The radiotherapy market is projected to reach USD 7.0 billion by 2024 from USD 5.6 billion in 2018, at a CAGR of 4.1%
Global Radiotherapy Market Opportunities:
The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.
Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567
Global Market Segmentation:
Based on application, the external beam radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The prostate cancer segment is expected to account for the second-largest share of the radiotherapy in 2018. The growing incidence of prostate cancer and the high success rates and minimal long-term risks achieved with external beam radiotherapy are the major factors driving the growth of this market segment.
Based on type, the external beam radiotherapy market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT. The IMRT segment is further classified into VMAT and TomoTherapy. The particle beam therapy segment is expected to witness the highest CAGR during the forecast period. Advancements in the field of particle beam therapy (such as PBS) and increasing research activities in the field of radiation oncology using proton therapy systems are the key factors driving the growth of this segment.
Based on end user, the market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment is expected to account for the largest share of the market in 2018 owing to the rising global prevalence of cancer, increasing installations of advanced radiotherapy equipment in developed as well as developing regions.
Geographical Analysis:
The radiotherapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The North American region is expected to account for the largest share of the radiotherapy industry in 2018. The rising incidence of cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and favorable government initiatives that are creating awareness and promoting the adoption of radiotherapy among key end users are some of the major factors driving the growth of the radiotherapy industry in North America.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=567
Key Market Players:
The major players operating in the radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US).
Radiotherapy a $7.0 billion Industry with a Promising Future in Cancer Treatment
Chemotherapy drugs are medicines used to treat cancer.
These drugs either kill or prevent the growth and division of cancer cells.
Chemotherapy treatment may be given before or after surgery, or to boost radiotherapy.
In advanced cancer, chemotherapy is used to stop and slow down the spread of cancer.
Distinctive market improvement activities and business methodologies utilized by industry players to beat macroeconomic conditions, including new thing/organization progression, joint undertakings, associations, unions and acquisitions, and so forth, are referred to in the report.
The association profiles for the Worldwide Ophthalmic Occluder Market contain a business diagram, thing/organization commitments, SWOT Analysis, part and full scale pay, gross edge, and percent piece of the general business.To clarify the moving toward adventure pockets, the assessment recalls for significance examination, most recent things, and future guesses of the Ophthalmic Occluder Market.
The parts that drive and limit the advancement of the Ophthalmic Occluder Market are altogether reviewed.
Porter’s Five Forces study complements the power of buyers and suppliers in aiding accomplices in making fundamental business decisions and choosing the level of industry force.
Expansive assessments of key mechanical areas help in understanding the different sorts of things and advances used in different bits of the world.In light of districts, the Ophthalmic Occluder Market report covers the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a piece of the Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as an element of South America.Get a Sample Copy of the Report to understand the structure of the complete reporthttps://www.oneupbusinessinsights.com/request_sample.php?tname=316848Top key players: Gulden Ophthalmics, Good-Lite, Blundell Harling, Precision Vision, GOLGATHA company, and Elbee Medical DevicesSegmentation of Ophthalmic Occluder Market:Product Type CoveragePlasticAlloyApplication CoverageHospitalClinicOtherOphthalmic Occluder Market: Regional Segment AnalysisMore Information:The report includes :1.)
The Asia Ophthalmic Occluder Market;3.)
The global image-guided therapy systems market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028.
The rise in the geriatric population and shifting preference for minimally invasive surgeries, along with technological advancements in imaging systems, are the key factors driving the market.According to the United Nations-World Population Prospects, 2019, about 16% of the global population or one in six people will be aged above 65 by 2050, up from 9% in 2019.
According to the WHO, the global cause of death is shifting from infections to chronic conditions, including high cholesterol, hypertension, cancer, and cognitive heart diseases.
Thus, the demand for image-guided therapy systems for treating these conditions is expected to rise in the coming years.For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/image-guided-therapy-systems-market/request/rs1 Key Player Mentioned:Koninklijke Philips N.V.MedtronicSiemens HealthineersAnalogic CorporationGE HealthcareVarian Medical Systems, Inc.According to the Institute of Cancer Research, more than 120,000 people in the U.K. are treated with radiotherapy annually.
Image-guided therapy systems have significantly improved, resulting in more precise and safer interventions.
Product Segment Analysis: Ultrasound SystemsComputed Tomography (CT) ScannersPositron Emission Tomography (PET)EndoscopesMagnetic Resonance Imaging (MRI)Application Segment Analysis:Cardiac SurgeryNeurosurgeryOrthopedic SurgeryUrologyOncology SurgeryRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Segment is also projected to expand at the fastest CAGR during the forecast period owing to technological advancements in endoscopy and subsequent product launches.
The detailed and latest study report entitled “Global Oncology/Cancer Drugs Market 2027” presents professional and up-to-date information on the global Oncology/Cancer Drugs Market industry.
It also provides a useful description of every phase and rising industry trends.This study report will permit the readers to focus on the Oncology/Cancer Drugs Market product description, current competitive players in the market, and the market revenue with profitability.
Considering the geographic regions, the market is split into various regions like North and South America, Europe, Middle-East and Africa, Asia-Pacific.To help key decision-makers, the report includes a competitive depicting of the leading players in the Global Oncology/Cancer Drugs Market, tempting investment plans, market positioning of important manufacturers sections.The Top Manufacturers/Prime Players covering the Global Oncology/Cancer Drugs Market are;The key companies profiled in the report include AbbVie Inc. Amgen, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc.Get Detailed COVID-19 Impact Analysis on the Oncology/Cancer Drugs Market@ https://www.alliedmarketresearch.com/request-for-customization/121?reqfor=covid Future Scope:The report scope consolidates a nitty-gritty examination of Worldwide Oncology/Cancer Drugs Market 2030 with the apprehension given in the headway of the business in specific regions.The Top Organizations Report is intended to contribute our purchasers with a preview of the business’ most persuasive players.
In addition, data on the exhibition of various organizations, benefits, net edge, vital activity, and more are introduced through different assets, for example, tables, diagrams, and information realistic.Covid-19 Scenario:Owing to the Covid-19 pandemic, autonomous weapons production was affected considerably.
Disruption in the supply chain of raw materials, challenges regarding logistics, lowered spending in the defense sector by various countries, and others posed restraints in manufacturing with full capacity.The lockdown measures implemented in many countries forced the defense systems manufacturers to halt the production partially or completely.
This, in turn, led to reduced purchase orders and affected the autonomous weapons market.Request for Customization of This Report @ https://www.alliedmarketresearch.com/request-for-customization/121 About Us:Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon.
The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.
This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.
The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028.
The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.The MRI-guided radiation therapy systems market report includes global as well as emerging players:Elekta ABVIEWRAY TECHNOLOGIES, INC.Device Technologies Australia Pty Ltd.OthersThe study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market.
It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree.
In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.Hospitals Remain the Target Customers for Market PlayersThe study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019.
Radiotherapy Market Research Report: Information by Type [External Beam Radiation Therapy (Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Tomotherapy, Stereotactic Radio Surgery, Stereotactic Body Radiation Therapy, and Proton Therapy), Internal Radiation Therapy and Systemic Radiation Therapy], Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer, and others), Equipment (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems), End-User (Hospitals and Independent Radiotherapy Centers) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Global Forecast till 2027Radiotherapy Market HighlightsRadiotherapy or radiation therapy is a treatment designed to reduce the size of tumors, blood disorders, and thyroid disease.
The global radiotherapy market report by Market Research Future (MRFR) contains useful insights deemed to assist market players in their strategies for the period between 2019 to 2025 (forecast period).Market OutlookThe global radiotherapy market size is expected to showcase a CAGR of 4.7% during the forecast period due to high prevalence of cancer cases.
The preference of radiotherapy as a line of treatment for reducing and eliminating malignant tumors can drive the market growth.
Technological advances in radiation therapy as well as continuous clinical trials for testing new drugs to reduce the effects of the treatment can bode well for the market.Adoption of radiotherapy for the treatment of various cancers as well as procurement of latest devices and drugs for palliative care of cancer patients can spur the market demand till 2025.
Government investments in research of radiotherapy can facilitate market growth.However, low access as well as unavailability of treatments at affordable prices can hamper market growth.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/1526SegmentationThe global radiotherapy market has been segmented based on type, application, end user, and region.The global radiotherapy market, based on type, has been segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy.
On the basis of the type segment, the external beam radiation therapy segment is expected to hold a major share in the market due to the reduced risk of radiation exposure during the treatment and the increased precision and accuracy of tumor targeting.The global radiotherapy market, based on application, has been segmented into skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer, and others.The global radiotherapy market, based on equipment, has been segmented into linear accelerators, radiation therapy simulators, and treatment planning systems.The global radiotherapy market, based on end use, has been segmented into hospitals and independent radiotherapy centers.Regional Analysis Based on region, the radiotherapy market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).The Americas is expected to dominate the global radiotherapy market due to novel treatment discovered in targeted therapy and the rise in per capita expenditure in healthcare.
Many organisations provide Australia and New Zealand Custom Procedure Trays and Packs.
Botox, facelifts, laser hair removal, rhinoplasty, and a variety of other cosmetic treatments are all performed with these trays.
The major purpose of these trays is to keep the skin safe while the treatment is being performed.
They do, however, differ in terms of style.
Some are small and sleek, while others are big and cartoonish in appearance.These Australia and New Zealand Custom Procedure Trays and Packs may usually be bought online.
They can be bought with particular instructions and information about the procedures that can be performed on them.During a procedure, custom trays are utilised to retain materials under the patient's teeth.
Radiology Center at Harding, a leading provider of top-quality medical imaging services to patients in Morris County and neighboring areas, has set up Hitachi's SOFIA 3D Whole Breast Ultrasound at its facilities.
Dense breasts and breast cancer: myth versus reality Breast cancer is among the leading causes of cancer-related deaths in women – second only to lung cancer.
So far, mammography remains the only screening technique that has proved effective in diagnosing breast cancer time and again.
Lack of awareness about the availability and significance of advanced supplementary screening technologies, like ultrasound, is also a factor.
A relatively painless, risk-free, efficient and less time-consuming technology that can be reimbursed by private health insurance players is the need of the hour.
In fact, because breast density poses additional risks, state governments (36 states as of 2019) have passed legislation that requires providers to inform women of their breast density status and discuss what it means and what supplemental imaging options are available that can help detect breast cancer, earlier.
According to the new market research report by MarketsandMarkets, [128 Pages Report] the global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.The report provides an overall understanding of the market.
The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468The Passive Approximators segment to grow at the highest CAGR during the forecast periodOn the basis of type, the global vascular closure device market is segmented into passive approximators, active approximators, and external hemostatic devices.
The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery.
The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the marketVascular closure devices are relatively high-priced devices compared to manual compression devices.
The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods.
Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls.
Chemotherapy drugs are medicines used to treat cancer.
These drugs either kill or prevent the growth and division of cancer cells.
Chemotherapy treatment may be given before or after surgery, or to boost radiotherapy.
In advanced cancer, chemotherapy is used to stop and slow down the spread of cancer.
The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.
This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.
The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028.
The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.The MRI-guided radiation therapy systems market report includes global as well as emerging players:Elekta ABVIEWRAY TECHNOLOGIES, INC.Device Technologies Australia Pty Ltd.OthersThe study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market.
It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree.
In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.Hospitals Remain the Target Customers for Market PlayersThe study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019.
Radiotherapy Market Research Report: Information by Type [External Beam Radiation Therapy (Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Tomotherapy, Stereotactic Radio Surgery, Stereotactic Body Radiation Therapy, and Proton Therapy), Internal Radiation Therapy and Systemic Radiation Therapy], Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer, and others), Equipment (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems), End-User (Hospitals and Independent Radiotherapy Centers) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Global Forecast till 2027Radiotherapy Market HighlightsRadiotherapy or radiation therapy is a treatment designed to reduce the size of tumors, blood disorders, and thyroid disease.
The global radiotherapy market report by Market Research Future (MRFR) contains useful insights deemed to assist market players in their strategies for the period between 2019 to 2025 (forecast period).Market OutlookThe global radiotherapy market size is expected to showcase a CAGR of 4.7% during the forecast period due to high prevalence of cancer cases.
The preference of radiotherapy as a line of treatment for reducing and eliminating malignant tumors can drive the market growth.
Technological advances in radiation therapy as well as continuous clinical trials for testing new drugs to reduce the effects of the treatment can bode well for the market.Adoption of radiotherapy for the treatment of various cancers as well as procurement of latest devices and drugs for palliative care of cancer patients can spur the market demand till 2025.
Government investments in research of radiotherapy can facilitate market growth.However, low access as well as unavailability of treatments at affordable prices can hamper market growth.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/1526SegmentationThe global radiotherapy market has been segmented based on type, application, end user, and region.The global radiotherapy market, based on type, has been segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy.
On the basis of the type segment, the external beam radiation therapy segment is expected to hold a major share in the market due to the reduced risk of radiation exposure during the treatment and the increased precision and accuracy of tumor targeting.The global radiotherapy market, based on application, has been segmented into skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer, and others.The global radiotherapy market, based on equipment, has been segmented into linear accelerators, radiation therapy simulators, and treatment planning systems.The global radiotherapy market, based on end use, has been segmented into hospitals and independent radiotherapy centers.Regional Analysis Based on region, the radiotherapy market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).The Americas is expected to dominate the global radiotherapy market due to novel treatment discovered in targeted therapy and the rise in per capita expenditure in healthcare.
Distinctive market improvement activities and business methodologies utilized by industry players to beat macroeconomic conditions, including new thing/organization progression, joint undertakings, associations, unions and acquisitions, and so forth, are referred to in the report.
The association profiles for the Worldwide Ophthalmic Occluder Market contain a business diagram, thing/organization commitments, SWOT Analysis, part and full scale pay, gross edge, and percent piece of the general business.To clarify the moving toward adventure pockets, the assessment recalls for significance examination, most recent things, and future guesses of the Ophthalmic Occluder Market.
The parts that drive and limit the advancement of the Ophthalmic Occluder Market are altogether reviewed.
Porter’s Five Forces study complements the power of buyers and suppliers in aiding accomplices in making fundamental business decisions and choosing the level of industry force.
Expansive assessments of key mechanical areas help in understanding the different sorts of things and advances used in different bits of the world.In light of districts, the Ophthalmic Occluder Market report covers the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a piece of the Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as an element of South America.Get a Sample Copy of the Report to understand the structure of the complete reporthttps://www.oneupbusinessinsights.com/request_sample.php?tname=316848Top key players: Gulden Ophthalmics, Good-Lite, Blundell Harling, Precision Vision, GOLGATHA company, and Elbee Medical DevicesSegmentation of Ophthalmic Occluder Market:Product Type CoveragePlasticAlloyApplication CoverageHospitalClinicOtherOphthalmic Occluder Market: Regional Segment AnalysisMore Information:The report includes :1.)
The Asia Ophthalmic Occluder Market;3.)
Many organisations provide Australia and New Zealand Custom Procedure Trays and Packs.
Botox, facelifts, laser hair removal, rhinoplasty, and a variety of other cosmetic treatments are all performed with these trays.
The major purpose of these trays is to keep the skin safe while the treatment is being performed.
They do, however, differ in terms of style.
Some are small and sleek, while others are big and cartoonish in appearance.These Australia and New Zealand Custom Procedure Trays and Packs may usually be bought online.
They can be bought with particular instructions and information about the procedures that can be performed on them.During a procedure, custom trays are utilised to retain materials under the patient's teeth.
Radiology Center at Harding, a leading provider of top-quality medical imaging services to patients in Morris County and neighboring areas, has set up Hitachi's SOFIA 3D Whole Breast Ultrasound at its facilities.
Dense breasts and breast cancer: myth versus reality Breast cancer is among the leading causes of cancer-related deaths in women – second only to lung cancer.
So far, mammography remains the only screening technique that has proved effective in diagnosing breast cancer time and again.
Lack of awareness about the availability and significance of advanced supplementary screening technologies, like ultrasound, is also a factor.
A relatively painless, risk-free, efficient and less time-consuming technology that can be reimbursed by private health insurance players is the need of the hour.
In fact, because breast density poses additional risks, state governments (36 states as of 2019) have passed legislation that requires providers to inform women of their breast density status and discuss what it means and what supplemental imaging options are available that can help detect breast cancer, earlier.
The global image-guided therapy systems market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028.
The rise in the geriatric population and shifting preference for minimally invasive surgeries, along with technological advancements in imaging systems, are the key factors driving the market.According to the United Nations-World Population Prospects, 2019, about 16% of the global population or one in six people will be aged above 65 by 2050, up from 9% in 2019.
According to the WHO, the global cause of death is shifting from infections to chronic conditions, including high cholesterol, hypertension, cancer, and cognitive heart diseases.
Thus, the demand for image-guided therapy systems for treating these conditions is expected to rise in the coming years.For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/image-guided-therapy-systems-market/request/rs1 Key Player Mentioned:Koninklijke Philips N.V.MedtronicSiemens HealthineersAnalogic CorporationGE HealthcareVarian Medical Systems, Inc.According to the Institute of Cancer Research, more than 120,000 people in the U.K. are treated with radiotherapy annually.
Image-guided therapy systems have significantly improved, resulting in more precise and safer interventions.
Product Segment Analysis: Ultrasound SystemsComputed Tomography (CT) ScannersPositron Emission Tomography (PET)EndoscopesMagnetic Resonance Imaging (MRI)Application Segment Analysis:Cardiac SurgeryNeurosurgeryOrthopedic SurgeryUrologyOncology SurgeryRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Segment is also projected to expand at the fastest CAGR during the forecast period owing to technological advancements in endoscopy and subsequent product launches.
According to the new market research report by MarketsandMarkets, [128 Pages Report] the global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.The report provides an overall understanding of the market.
The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468The Passive Approximators segment to grow at the highest CAGR during the forecast periodOn the basis of type, the global vascular closure device market is segmented into passive approximators, active approximators, and external hemostatic devices.
The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery.
The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the marketVascular closure devices are relatively high-priced devices compared to manual compression devices.
The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods.
Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls.
The detailed and latest study report entitled “Global Oncology/Cancer Drugs Market 2027” presents professional and up-to-date information on the global Oncology/Cancer Drugs Market industry.
It also provides a useful description of every phase and rising industry trends.This study report will permit the readers to focus on the Oncology/Cancer Drugs Market product description, current competitive players in the market, and the market revenue with profitability.
Considering the geographic regions, the market is split into various regions like North and South America, Europe, Middle-East and Africa, Asia-Pacific.To help key decision-makers, the report includes a competitive depicting of the leading players in the Global Oncology/Cancer Drugs Market, tempting investment plans, market positioning of important manufacturers sections.The Top Manufacturers/Prime Players covering the Global Oncology/Cancer Drugs Market are;The key companies profiled in the report include AbbVie Inc. Amgen, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc.Get Detailed COVID-19 Impact Analysis on the Oncology/Cancer Drugs Market@ https://www.alliedmarketresearch.com/request-for-customization/121?reqfor=covid Future Scope:The report scope consolidates a nitty-gritty examination of Worldwide Oncology/Cancer Drugs Market 2030 with the apprehension given in the headway of the business in specific regions.The Top Organizations Report is intended to contribute our purchasers with a preview of the business’ most persuasive players.
In addition, data on the exhibition of various organizations, benefits, net edge, vital activity, and more are introduced through different assets, for example, tables, diagrams, and information realistic.Covid-19 Scenario:Owing to the Covid-19 pandemic, autonomous weapons production was affected considerably.
Disruption in the supply chain of raw materials, challenges regarding logistics, lowered spending in the defense sector by various countries, and others posed restraints in manufacturing with full capacity.The lockdown measures implemented in many countries forced the defense systems manufacturers to halt the production partially or completely.
This, in turn, led to reduced purchase orders and affected the autonomous weapons market.Request for Customization of This Report @ https://www.alliedmarketresearch.com/request-for-customization/121 About Us:Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon.